Inquilinus limosus isolated from a cystic fibrosis patient: First UK report

British Journal of Biomedical Science

Volumn 64, Issue 3, 2007, Pages 127-129

  Cooke, R P D ^a,c   O'Neill, W A ^a   Xu, J ^b   Moore, J E ^b   Elborn, J S ^b  

^a EASTBOURNE DISTRICT GENERAL HOSPITAL   (United Kingdom)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^c UNIVERSITY HOSPITAL AINTREE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; ANTIBIOTIC AGENT; CARBENICILLIN; CEFTAZIDIME; CIPROFLOXACIN; GENTAMICIN; TICARCILLIN; TOBRAMYCIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CULTURE; BURKHOLDERIA CEPACIA; CASE REPORT; CYSTIC FIBROSIS; FEMALE; GRAM NEGATIVE BACTERIUM; HUMAN; INQUILINUS LIMOSUS; ISOLATION PROCEDURE; MAINTENANCE THERAPY; MICROORGANISM; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RHIZOBIUM RADIOBACTER; SCHOOL CHILD; SPUTUM; UNITED KINGDOM;

INQUILINUS LIMOSUS;

EID: 34748842573     PISSN: 09674845     EISSN: None     Source Type: Journal    
DOI: 10.1080/09674845.2007.11732772     Document Type: Article

References (13)

1. LiPuma JJ. Burkholderia cepacia epidemiology and pathogenesis: implications for infection control. Curr Opin Pulm Med 1998; 4: 337-441.
2. LiPuma JJ, Dulaney BJ, McMenamin JD et al. Development of rRNA-based PCR assays for identification of Burkholderia cepacia complex isolates recovered from cystic fibrosis patients. J Clin Microbiol 1999; 37: 3167-70.
3. Coenye T, Goris J, Spilker T, Vandamme P, LiPuma JJ. Characterization of unusual bacteria isolated from respiratory secretions of cystic fibrosis patients and description of Inquilinus limosus gen. nov, sp. nov. J Clin Microbiol 2002; 40: 2062-9.
4. Wellinghausen N, Esiig A, Sommerburg O. Inquilinus limosus in patients with cystic fibrosis, Germany. Emerg Infect Dis 2005; 11: 457-9.
5. Chiron R, Marchandin H, Counil F et al. Clinical and microbiological features of Inquilinus spp. isolates from five patients with cystic fibrosis. J Clin Microbiol 2005; 43: 3938-43.
6. Millar BC, Xu J, Moore JE. Risk assessment models and contamination management: implications for broad-range ribosomal DNA PCR as a diagnostic tool in medical bacteriology. J Clin Microbiol 2002; 40: 1575-80.
7. Campbell PW, Phillips JA, Heidecker GJ, Krishnamani MR, Zahorchak R, Stull TL. Detection of Pseudomonas (Burkholderia) cepacia using PCR. Pediatr Pulmonol 1995; 20: 44-9.
8. Goldenberger D, Kunzli A, Vogt P, Zbinden R, Altwegg M. Molecular diagnosis of bacterial endocarditis by broad-range PCR amplification and direct sequencing. J Clin Microbiol 1997; 35: 2733-9.
9. Evans LR, Linker A, Impallomeni G. Structure of succinoglycan from an infectious strain of Agrobacterium radiobacter. Int J Biol Macromol 2000; 27: 319-26.
10. Pitulle C, Citron DM, Bochner B, Barbers R, Appleman MD. Novel bacterium isolated from a lung transplant patient with cystic fibrosis. J Clin Microbiol 1999; 37: 3851-5.
11. Garske L, Moore JE, Crowe MJ, Elborn JS. Cystic fibrosis and guidelines to assess significance of new colonisers? Ir J Med Sci 2002; 171: 116-7.
12. Wellinghausen, Kothe J, Wirths B, Sigge A, Poppert S. Superiority of molecular techniques for identification of Gram-negative, oxidase-positive rods, including morphologically non-typical Pseudomonas aeruginosa, from patients with cystic fibrosis. J Clin Microbiol 2005; 43: 4070-5.
13. Schmoldt S, Latzin P, Heesemann J, Griese M, Imhof A, Hogardt M. Clonal analysis of Inquilinus limosus from six cystic fibrosis patients and specific serum antibody response. J Med Microbiol 2006; 55: 1425-33.